Epipole

company

About

Epipole is an innovative, engineering-led company tackling the causes of preventable blindness.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£1.30M
Industries
Medical Device
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

Epipole are a UK-based retinal imaging company. Epipole was founded in January 2011 with the express aim of building intellectual property in the application areas of image processing, 3D and medical imaging. We have developed the epiCam family of retinal video devices, which launched in 2016. They are now disrupting the ophthalmic device space and introducing clinicians to entirely new ways of working and understanding retinal imagery - and in some cases helping to generate entirely new science. The epiCam V veterinary variant was launched in 2017, enabling high quality fundus imaging of a variety of animals.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
£2.80M
Epipole has raised a total of £2.80M in funding over 2 rounds. Their latest funding was raised on Jan 20, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 20, 2022 Series Unknown £1.30M 1 Greenwood Way Capital Detail
Jun 24, 2020 Series Unknown £1.50M 1 Greenwood Way Capital Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Epipole is funded by 1 investors. Greenwood Way Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Greenwood Way Capital Yes Series Unknown